Array ( [REDIRECT_SCRIPT_URL] => /print/1153706 [REDIRECT_SCRIPT_URI] => http://www.genomeweb.com/print/1153706 [REDIRECT_STATUS] => 200 [SCRIPT_URL] => /print/1153706 [SCRIPT_URI] => http://www.genomeweb.com/print/1153706 [HTTP_HOST] => www.genomeweb.com [HTTP_USER_AGENT] => CCBot/2.0 [HTTP_ACCEPT_LANGUAGE] => en-us,en-gb,en;q=0.7,*;q=0.3 [HTTP_ACCEPT] => text/html,application/xhtml+xml,application/xml;q=0.9,*/*;q=0.8 [HTTP_ACCEPT_ENCODING] => gzip [HTTP_X_FORWARDED_FOR] => 23.22.76.170, 23.22.76.170 [HTTP_X_VARNISH] => 1568987307 [PATH] => /sbin:/usr/sbin:/bin:/usr/bin [SERVER_SIGNATURE] => Apache/2.2.3 (CentOS) Server at www.genomeweb.com Port 80 [SERVER_SOFTWARE] => Apache/2.2.3 (CentOS) [SERVER_NAME] => www.genomeweb.com [SERVER_ADDR] => 127.0.0.1 [SERVER_PORT] => 80 [REMOTE_ADDR] => 23.22.76.170 [DOCUMENT_ROOT] => /var/www/genomeweb.com/htdocs [SERVER_ADMIN] => root@localhost [SCRIPT_FILENAME] => /var/www/genomeweb.com/htdocs/index.php [REMOTE_PORT] => 37835 [REDIRECT_QUERY_STRING] => q=print/1153706 [REDIRECT_URL] => /print/1153706 [GATEWAY_INTERFACE] => CGI/1.1 [SERVER_PROTOCOL] => HTTP/1.1 [REQUEST_METHOD] => GET [QUERY_STRING] => q=print/1153706 [REQUEST_URI] => /print/1153706 [SCRIPT_NAME] => /index.php [PHP_SELF] => /index.php [REQUEST_TIME] => 1369314960 ) Alnylam Amends Year-End Financial Guidance to Reflect Tekmira Payout Drupal.behaviors.print = function(context) {window.print();window.close();}> Alnylam Amends Year-End Financial Guidance to Reflect Tekmira Payout November 15, 2012 Alnylam Amends Year-End Financial Guidance to Reflect Tekmira Payout Full-text access for premium subscribers only. Existing premium subscribers login here. New to GenomeWeb? Register here quickly. Related StoriesIP Update: Recent Patents, Patent Applications Awarded to Alnylam, Novartis, Tekmira, and More May 21, 2013 / Gene Silencing News Tekmira on Track to Move Cancer Drug into Phase II, Name New Clinical Candidate in ‘13 May 16, 2013 / Gene Silencing News Alnylam Loses Cubist as RSV Partner, Stays Focused on ATTR Programs February 14, 2013 / Gene Silencing News Alnylam, Tekmira Shares Regain Lost Ground Heading into 2013 January 24, 2013 / Gene Silencing News Alnylam to Sell $125M in Stock January 17, 2013 / Gene Silencing News